FDA Drug Interaction Draft Guidance for Therapeutic Proteins

The draft guidance newly released by FDA on “Drug-Drug Interaction Assessment of Therapeutics Proteins” is now available in DIDB Resource Center. Please note that you must be signed in to access.

For your information, in addition to small molecules, DIDB also contains drug-drug interaction data for therapeutic proteins extracted from literature and FDA biological license applications (BLAs).